Recent News

• 12.03.2025 - Sutro Biopharma Announces First Cohort of Patients Dosed in Phase 1 Trial of STRO-004, a Next-Generation Tissue Factor ADC, in TF-Expressing Solid Tumors
• 12.01.2025 - Sutro Biopharma Announces 1-for-10 Reverse Stock Split
• 11.12.2025 - Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day
• 11.06.2025 - Sutro Biopharma Reports Third Quarter 2025 Financial Results and Business Highlights
• 11.05.2025 - Sutro Biopharma to Host Virtual Research & Development Day on November 12, 2025
• 09.29.2025 - Sutro Biopharma Announces Operational Restructuring Intended to Extend Cash Runway through Key Milestones

Recent Filings

• 11.06.2025 - EX-99.1 EX-99.1
• 11.06.2025 - 8-K Current report
• 11.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 10.23.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 10.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.29.2025 - 8-K Current report